TheEdgeResearch
Home / Stocks / FAMDF

Futura Medical plc (FAMDF)

OTC Healthcare Biotechnology
$0.01 ▲ +495.24%
Market Cap
$4.2M
Sector
Healthcare
Industry
Biotechnology
Beta
0.02
52-Wk Range
0.0013-0.2
CEO
Alex Duggan
Country
GB
Currency
USD

Futura Medical plc is a pharmaceutical company that formulates and brings to market healthcare solutions and medicines for the consumer sector, primarily concentrating on sexual well-being and managing discomfort. Their flagship product, MED3000, is a topical gel specifically developed to address erectile dysfunction. The company's pipeline also encompasses a range of pain relief treatments, featuring TPR100, a topical diclofenac gel; CBD100, a topical cannabidiol preparation; and TIB200, a topical ibuprofen gel. Established in 2001, Futura Medical plc operates from its headquarters located in…

Open full interactive analysis & DCF →